News
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Education news: Long odds all that remain between Athlos Academy and closure Minneapolis-based WhiteBox Marketing helped with ...
MLB Opening Day 2025 is finally upon us and all eyes will be on the Los Angeles Dodgers after their World Series win in 2024. The Dodgers technically already opened their season with a sweep of ...
Thursday marks 27 years since the U.S. Food and Drug Administration approved the sale of Viagra, the nation’s first oral medication for what’s now commonly known as erectile dysfunction.
In the US prescribing information, where acoramidis is approved under the brand name Attruby™, the most common side effects were mild and included diarrhea and abdominal pain that were resolved ...
BEP is a combination chemotherapy treatment that healthcare professionals primarily use for treating testicular cancer. They may also use BEP to treat certain types of ovarian cancer and tumors ...
The Signal messaging app, where senior US officials exchanged military plans in a chat group that included a journalist, is an approved application, the White House said Wednesday. "First of all ...
A former U.S. FDA employee said he and other agency reviewers were pressured to approve Humacyte's (NASDAQ:HUMA) Symvess, an artificial blood vessel, despite safety concerns. The implantable ...
The Food and Drug Administration on Wednesday approved the first treatment for the insatiable hunger associated with the rare disease Prader-Willi syndrome, a long-awaited decision that follows an ...
It’s unclear if Signal, an app that offers encryption as well as features like disappearing messages, is an approved platform. “As the National Security Council stated, the White House is look ...
In a report released today, Robert Kad from Morgan Stanley maintained a Buy rating on Brookfield Renewable Partners (BEP – Research Report), with a price target of $32.00. The company’s shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results